Notwithstanding the multiple systematic meta-analysis that addressed the impact of Sox2 [40], nestin [41], and vimentin [42] as independent predictors in human lung cancer prognosis, two reports demonstrated the clinicopathological and prognostic significance of the nucleolin expression in lung cancer patients. This evidence concerns the gene SOX2 and lung carcinoma.